Skip to main content
Article thumbnail
Location of Repository

Rapid Influx and Death of Plasmacytoid Dendritic Cells in Lymph Nodes Mediate Depletion in Acute Simian Immunodeficiency Virus Infection

By Kevin N. Brown, Viskam Wijewardana, Xiangdong Liu and Simon M. Barratt-Boyes


Plasmacytoid dendritic cells (pDC) are essential innate immune system cells that are lost from the circulation in human immunodeficiency virus (HIV)–infected individuals associated with CD4+ T cell decline and disease progression. pDC depletion is thought to be caused by migration to tissues or cell death, although few studies have addressed this directly. We used precise methods of enumeration and in vivo labeling with 5-bromo-2′-deoxyuridine to track recently divided pDC in blood and tissue compartments of monkeys with acute pathogenic simian immunodeficiency virus (SIV) infection. We show that pDC are lost from blood and peripheral lymph nodes within 14 days of infection, despite a normal frequency of pDC in bone marrow. Paradoxically, pDC loss masked a highly dynamic response characterized by rapid pDC mobilization into blood and a 10- to 20-fold increase in recruitment to lymph nodes relative to uninfected animals. Within lymph nodes, pDC had increased levels of apoptosis and necrosis, were uniformly activated, and were infected at frequencies similar to CD4+ T cells. Nevertheless, remaining pDC had essentially normal functional responses to stimulation through Toll-like receptor 7, with half of lymph node pDC producing both TNF-α and IFN-α. These findings reveal that cell migration and death both contribute to pDC depletion in acute SIV infection. We propose that the rapid recruitment of pDC to inflamed lymph nodes in lentivirus infection has a pathologic consequence, bringing cells into close contact with virus, virus-infected cells, and pro-apoptotic factors leading to pDC death

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2007). Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.
    2. (2007). Aldovini A
    3. (2006). Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors.
    4. (2008). Characterization of plasmacytoid dendritic cells in bone marrow of pig-tailed macaques.
    5. (2008). Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics.
    6. (2002). Clone B7 cells have a single copy of SIVsmB7 integrated in chromosome 20.
    7. (2001). Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.
    8. (2007). Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.
    9. (2001). Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients.
    10. (2005). Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.
    11. (2007). Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells.
    12. (2008). Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections.
    13. (2003). Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1.
    14. (2001). Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection.
    15. (2008). Effect of SIVmac infection on plasmacytoid and CD1c+ myeloid dendritic cells in cynomolgus macaques.
    16. (2007). Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.
    17. (2005). Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor- viral RNA interactions.
    18. (2004). Endogenous IFN-alpha production by plasmacytoid dendritic cells exerts an antiviral effect on thymic HIV-1 infection.
    19. (2004). Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules.
    20. (2003). Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.
    21. (1995). Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
    22. (2004). Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques.
    23. (1998). Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.
    24. (2009). HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques.
    25. (2005). Hosmalin A
    26. (2004). Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells.
    27. (2005). Impact of bone marrow hematopoiesis failure on T-cell generation during pathogenic simian immunodeficiency virus infection in macaques.
    28. (2007). Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells.
    29. (1986). In vivo thymocyte maturation. BUdR labeling of cycling thymocytes and phenotypic analysis of their progeny support the single lineage model.
    30. (2002). Increased expression of the inflammatory chemokine CXC chemokine ligand 9/ monokine induced by interferon-gamma in lymphoid tissues of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.
    31. (2003). Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals.
    32. (2006). Iwasaki A
    33. (1996). Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection.
    34. (2001). Loss of blood CD11c(+) myeloid and CD11c(2) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.
    35. (2004). Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation.
    36. (2005). Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.
    37. (2006). Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
    38. (2007). Origin of dendritic cells in peripheral lymphoid organs of mice.
    39. (2007). Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS.
    40. (2005). Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early Tlymphocyte responses.
    41. (2005). Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.
    42. (2002). Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.
    43. (2005). Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.
    44. (2008). Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.
    45. (2001). Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus.
    46. (1999). Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.
    47. (2008). Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression.
    48. (2002). Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation.
    49. (2003). Protection from HIV/AIDS: the importance of innate immunity.
    50. (2001). Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection.
    51. (1999). Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.
    52. (2003). Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo.
    53. (2009). Surface phenotype and rapid quantification of blood dendritic cell subsets in the rhesus macaque. J Med Primatol; In press.
    54. (2004). Tarantal AF
    55. (2005). Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection.
    56. (2007). The interaction of HIV with dendritic cells: outcomes and pathways.
    57. (2000). The Ki-67 protein: from the known and the unknown.
    58. (1999). The nature of the principal type 1 interferon-producing cells in human blood.
    59. (2005). TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells.
    60. (2004). Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect.
    61. (2006). Type I interferon production in HIV-infected patients.
    62. (2005). Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.